Metraipolis › archive › dc_7ffbe46a78da

Use of faricimab for refractory diabetic macular edema in real-world clinical practice: When anatomical success meets functional limits — Europe PMC PMID:42777000

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42777000
DOI: 10.1371/journal.pone.0358993
License (as archived): solo-consultazione
Archived: 2026-10-07T22:54:01.444Z
SHA-256 of the archived text: bf399d831d6cd086fe8807b412554c09ac95a5c0264033ca497cd576cc3d9aac
Stable URL of this page: https://metraipolis.com/documento/dc_7ffbe46a78da

How to cite

Use of faricimab for refractory diabetic macular edema in real-world clinical practice: When anatomical success meets functional limits — Europe PMC PMID:42777000 — Europe PMC (en), https://europepmc.org/article/MED/42777000 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7ffbe46a78da (Metraipolis archive dc_7ffbe46a78da, sha256 bf399d831d6cd086fe8807b412554c09ac95a5c0264033ca497cd576cc3d9aac)

BibTeX

@misc{dc7ffbe46a78da,
  title = {Use of faricimab for refractory diabetic macular edema in real-world clinical practice: When anatomical success meets functional limits — Europe PMC PMID:42777000},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42777000},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7ffbe46a78da; sha256 bf399d831d6cd086fe8807b412554c09ac95a5c0264033ca497cd576cc3d9aac},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42777000. Agents can read the archived copy with the MCP tool read_document.